Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
14.38
+0.26 (1.84%)
At close: Apr 28, 2026, 4:00 PM EDT
14.21
-0.17 (-1.21%)
After-hours: Apr 28, 2026, 6:27 PM EDT
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $779.19 million as of April 28, 2026. Its market cap has increased by 900.95% in one year.
Market Cap
779.19M
Enterprise Value
326.98M
1-Year Change
900.95%
Ranking
Category
Stock Price
$14.38
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $779.19M, a decrease of -40.02%. That is a compound annual growth rate of -9.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 765.10M | 51.07% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 800.94M |
| Cullinan Therapeutics | 800.16M |
| Allogene Therapeutics | 794.59M |
| SpyGlass Pharma | 786.19M |
| Solid Biosciences | 779.29M |
| Design Therapeutics | 772.75M |
| Relmada Therapeutics | 756.24M |
| Tenax Therapeutics | 719.30M |